Ginkgo Bioworks Holdings, Inc. DNA
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -40.98M | -46.71M | -82.59M | -80.75M | -80.76M |
| Total Depreciation and Amortization | 7.84M | 8.22M | 8.60M | 8.96M | 9.52M |
| Total Amortization of Deferred Charges | 4.20M | 4.10M | 4.20M | 4.70M | 4.10M |
| Total Other Non-Cash Items | 15.54M | 3.27M | 37.28M | 43.00M | 24.44M |
| Change in Net Operating Assets | -14.94M | -13.15M | -14.18M | -23.59M | 11.08M |
| Cash from Operations | -28.35M | -44.27M | -46.69M | -47.68M | -31.61M |
| Capital Expenditure | -2.00M | -2.62M | -1.93M | -5.00K | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | 574.00K | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -22.10M | 13.71M | 25.07M | 94.53M | -72.82M |
| Cash from Investing | -24.10M | 11.09M | 23.13M | 95.10M | -72.82M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00 | 0.00 | -19.00K | -25.00K | -24.00K |
| Issuance of Common Stock | 6.75M | 17.05M | -- | 9.15M | 10.32M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -242.00K | -560.00K | -- | -985.00K | -355.00K |
| Cash from Financing | 6.50M | 16.49M | -19.00K | 8.14M | 9.94M |
| Foreign Exchange rate Adjustments | 6.00K | 43.00K | -129.00K | -152.00K | 93.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -45.94M | -16.65M | -23.70M | 55.41M | -94.39M |